Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences
Get Alerts DCPH Hot Sheet
Join SI Premium – FREE
WALTHAM, Mass.--(BUSINESS WIRE)-- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in fireside chats at the following investor conferences:
- Guggenheim Healthcare Talks Oncology Day on Thursday, February 9, 2023 at 10:45 AM ET in New York, NY
- SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023 at 3:00 PM ET (virtual)
A live webcast of both events will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/events-presentations. A replay of both webcasts will be archived on the Company’s website for 90 days following the presentation.
About Deciphera Pharmaceuticals
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s switch-control inhibitor for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Israel, New Zealand, Switzerland, Taiwan, the United Kingdom, and the United States. For more information, visit www.deciphera.com and follow us on LinkedIn and Twitter (@Deciphera).
View source version on businesswire.com: https://www.businesswire.com/news/home/20230202005015/en/
Investor Relations:
Maghan Meyers
Argot Partners
[email protected]
212-600-1902
Media:
David Rosen
Argot Partners
[email protected]
212-600-1902
Source: Deciphera Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Infinite Speakers' New Guide Covers 7 Speaker Booking Mistakes
- Dr Mahyar Amjadi Announces Plans to Expand Plastic Surgery and Skin Cancer Care Locations
- Charleston WV Medical Spa Returns to 828 Oakwood Road
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Twitter, GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share